Air Bubble in Your Semaglutide Injection: What the Evidence Says

A small air bubble in the pre-filled pen is normal and will not cause an embolism — subcutaneous tissue absorbs air safely.
Air displaces medicine, so a large bubble can mean you receive less than the intended dose; priming the pen correctly before each use minimises this.
Wegovy (semaglutide) pens are pre-primed by Novo Nordisk, you do not need to expel air manually the way you would with a drawn-up syringe; your patient leaflet covers the exact steps.
If you notice the pen looks unusual, the window is cloudy, or you are unsure whether a full dose was delivered, contact your prescriber before your next injection.

A small air bubble in a semaglutide injection pen is not dangerous. Official guidance from the Mounjaro and Wegovy SmPCs on the eMC and the manufacturers' patient leaflets confirms that air in a subcutaneous injection does not enter the bloodstream in a way that causes harm — the tissue under the skin simply absorbs it. What a bubble can do is slightly reduce the dose you receive, which is why the technique matters. These are prescription-only medicines assessed and prescribed on clinical grounds; everything below applies to patients already under prescriber supervision.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the patient guidance and clinical evidence tell you about bubbles, dosing and technique

Why bubbles appear in the pen, and why the leaflet says not to worry

Novo Nordisk's patient leaflet for Wegovy, as published on the eMC (the electronic Medicines Compendium), does not require you to remove air bubbles before injecting. This is deliberate engineering: the pre-filled auto-injector is designed and tested so that a small bubble at the top of the cartridge does not reduce the delivered dose in any clinically meaningful way. The drug is dispensed as a liquid held under slight pressure, and the plunger mechanism accounts for the small air space.

Where bubbles become relevant is technique. Holding the pen at an odd angle, shaking it, or storing it with the cap end down can shift a bubble toward the needle end, and if you are wondering what to do when your Wegovy pen has an air bubble you will find that priming in the correct position helps clear this. The standard semaglutide injection technique covers how to hold the pen correctly for each step.

Contrast this with a drawn-up syringe, where a clinician or nurse actively aspirates fluid and must expel air manually. Pre-filled pens exist partly to remove that step. If you have been taught to use a reusable pen with cartridges rather than the standard Wegovy auto-injector, your specific instructions may differ; always follow what your prescriber or leaflet says for your exact device.

The dose accuracy question: when does a bubble actually matter?

Clinical pharmacology research on subcutaneous biologics, referenced in NHS prescribing guidance, draws a distinction between cosmetic air (tiny bubbles that travel with the medicine without displacing it) and air that genuinely sits in front of the liquid and blocks part of the dose. For most patients using a correctly handled pre-filled pen, the bubble is cosmetic.

A bubble large enough to displace a meaningful volume of medicine is uncommon with a manufacturer-filled device, though our detailed guide on an air bubble in a Wegovy pen explains the circumstances in which this becomes more plausible, such as when a pen has been dropped, frozen and thawed (which can disrupt the cartridge seal), or if a needle has been left attached between injections, a known risk, because leftover medicine in the needle can draw air back into the cartridge as it cools. Attaching a fresh needle immediately before injection and removing it immediately after is the correct practice, covered in full in the patient leaflet.

The NHS medicines page for semaglutide advises patients to read the pen instructions carefully and to contact their prescriber or pharmacist if they have concerns about how a dose went. That remains the right first call if you suspect something went wrong with a specific injection.

Priming, injection depth, and the steps that actually reduce risk

Some people notice a bubble only because they are watching the inspection window closely, which is good practice, not a problem. The inspection window lets you confirm that the pen still contains medicine and that the liquid looks clear and colourless. Any cloudiness, discolouration, or visible particles are reasons to use a different pen and contact your pharmacy, not to proceed.

If you want to reduce the chance of a bubble forming in the first place, three habits help. First, take the pen from the fridge and let it reach room temperature for around 30 minutes before injecting, cold liquid is more prone to forming small bubbles as it warms inside the cartridge. Second, do not shake the pen. Third, attach the needle only when you are ready to inject. Injection depth is a related technique question: how deep to inject semaglutide explains the recommended skin-pinch and angle approach that ensures the medicine reaches the subcutaneous layer rather than sitting in the skin.

The approved injection sites (abdomen, upper thigh, or upper arm) should be rotated to prevent scar tissue building up, which can affect absorption. Our clinical team at nume (sorry, at nume) sees injection-technique questions regularly; it is far better to ask than to second-guess.

When to contact your prescriber or pharmacist

Most air-bubble questions resolve with technique review and a re-read of the leaflet. Contact your prescriber promptly if: the pen window appears empty after injecting but you are uncertain whether a full dose was delivered; the liquid looks cloudy, discoloured, or contains particles; the needle or device appears damaged; or you have injected the same site repeatedly and notice a lump, redness, or hardened area that is not settling.

Semaglutide (Wegovy) is a prescription-only medicine and your prescriber reviews your progress before every repeat supply. If you are newly starting treatment, the full Wegovy overview covers what to expect in the early weeks. Cost and supply questions come up too, Wegovy pricing in the UK explains what a legitimate private prescription includes. For anything urgent between review appointments, our support team is available seven days a week.

If you are considering starting semaglutide treatment and want your consultation reviewed by a real clinician the same day, you can start your free consultation with nume, your answers go to a GPhC-registered Independent Prescriber, not a scoring algorithm.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions